Sinclair's study is the first time this technology has been used in humans
BPC-157 5.0 1 review BPC-157 is a synthetic peptide studied for its role in cellular repair and tissue-related pathways in controlled research environments
Most peptides are rapidly degraded by digestive enzymes if taken orally
However, local concentration gradients may favor tissues nearest the injection point, at least initially after administration
Subanesthetic effects of the noncompetitive NMDA antagonist, ketamine, in humans: Psychotomimetic, perceptual, cognitive, and neuroendocrine responses
Additionally, TB-500 in commercial products refers specifically to the N-acetylated 1723 fragment (Ac-LKKTETQ), while the strongest peer-reviewed clinical and preclinical work was conducted on full-length thymosin beta-4 (RGN-259, RGN-352)